Q1 2002 Highlights
Continued Improvement in the
EPS - diluted $0.34 $0.45 $0.47
EBITDA Margin 3.4% 4.3% 4.1%
Cash from Operations $33M* $99M $70M**
Debt-to-Capital Ratio 36.8% 33.8% 29.8%
Return on Equity 16.8% 17.8% 18.8%
*- Excludes Government Settlement
**- Adjusted for timing of Medicare Payments